Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Day One Biopharmaceuticals, Inc. - Common Stock
(NQ:
DAWN
)
6.815
+0.435 (+6.82%)
Streaming Delayed Price
Updated: 1:56 PM EDT, Jun 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Day One Biopharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference
May 30, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations
May 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
7 Analysts Have This to Say About Day One Biopharmaceutical
May 18, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Day One Biopharmaceutical
April 25, 2023
Via
Benzinga
Analyst Expectations for Day One Biopharmaceutical's Future
April 05, 2023
Via
Benzinga
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
May 01, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 26, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
April 25, 2023
Via
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via
Benzinga
Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
April 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
What 8 Analyst Ratings Have To Say About Day One Biopharmaceutical
March 07, 2023
Via
Benzinga
Where Day One Biopharmaceutical Stands With Analysts
February 03, 2023
Via
Benzinga
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
April 12, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
March 06, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One to Participate in the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
What 7 Analyst Ratings Have To Say About Day One Biopharmaceutical
January 09, 2023
Via
Benzinga
This Pediatric Cancer Company Makes It To Analyst's Conviction List
December 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
February 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via
Benzinga
Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses
January 09, 2023
Via
Benzinga
Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma
January 08, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
